Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.84 USD | +33.33% | +71.96% | -67.30% |
May. 07 | Oragenics, Inc. Announces Partnership with Avance Clinical to Conduct Phase II Clinical Trial in Australia | CI |
Apr. 12 | North American Morning Briefing : Big Banks Kick -2- | DJ |
Financials (USD)
Sales 2022 | 0.13 | Sales 2023 | 0.04 | Capitalization | 14.46M |
---|---|---|---|---|---|
Net income 2022 | -14M | Net income 2023 | -20M | EV / Sales 2022 | 11,842,208 x |
Net cash position 2022 | 10.8M | Net cash position 2023 | 3.16M | EV / Sales 2023 | 299,979,895 x |
P/E ratio 2022 |
-0.89
x | P/E ratio 2023 |
-0.61
x | Employees | 5 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 76.77% |
1 day | +33.33% | ||
1 week | +71.96% | ||
Current month | +77.78% | ||
1 month | +49.59% | ||
3 months | -50.93% | ||
6 months | -48.89% | ||
Current year | -67.30% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Redmond
CEO | Chief Executive Officer | 64 | Dec. 27 |
Janet Huffman
DFI | Director of Finance/CFO | 52 | 23-03-06 |
Kimberly Murphy
BRD | Director/Board Member | 62 | 20-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Pope
CHM | Chairman | 73 | 10-06-03 |
John Gandolfo
BRD | Director/Board Member | 63 | 23-10-03 |
Robert Koski
BRD | Director/Board Member | 65 | 09-06-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 1.84 | +33.33% | 440,842 |
24-05-09 | 1.38 | +14.05% | 113,324 |
24-05-08 | 1.21 | -9.70% | 88,480 |
24-05-07 | 1.34 | +24.07% | 586,112 |
24-05-06 | 1.08 | +0.93% | 36,920 |
Delayed Quote Nyse, May 10, 2024 at 04:10 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-67.30% | 8.24M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- OGEN Stock